CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2026-06-09 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2026-04-21 | BAKER BROS. ADVISORS LP Director | Purchase · Warrants to purchase Common Stock | +114,601 | $4.44 | $509K | 1,678,273 |
| 2026-04-21 | BAKER BROS. ADVISORS LP Director | Purchase · Warrants to purchase Common Stock | +2,137,651 | $4.44 | $9.5M | 20,105,994 |
| 2025-06-12 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +76,000 | 76,000 | ||
| 2025-06-12 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +76,000 | 76,000 | ||
| 2024-06-14 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2024-06-14 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2023-12-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +593,452 | $3.15 | $1.9M | 1,563,672 |
| 2023-12-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +7,343,307 | $3.15 | $23.1M | 17,968,343 |
| 2023-06-16 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2023-06-16 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | ||
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Grant or award · Prelude Non-Voting Common Stock | +121,178 | $5.75 | $697K | 630,658 |
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Grant or award · Prelude Non-Voting Common Stock | +1,327,044 | $5.75 | $7.6M | 6,539,415 |
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +970,220 | $5.75 | $5.6M | 970,220 |
| 2023-05-22 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +10,625,036 | $5.75 | $61.1M | 10,625,036 |
| 2022-06-17 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +34,300 | 34,300 | ||
| 2021-06-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +23,344 | 23,344 | ||
| 2021-01-27 | BAKER BROS. ADVISORS LP Director | Option exercise | +5,188 | $12.85 | $67K | 876,061 |
| 2021-01-27 | BAKER BROS. ADVISORS LP Director | Option exercise | +5,188 | $12.85 | $67K | 9,252,951 |
Page 1 of 3 · 55 trades